SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
IDPH--Positive preliminary results for pivotal trial of ID
An SI Board Since June 1996
Posts SubjectMarks Bans Symbol
1762 27 0 IDPH
Emcee:  Roudy Type:  Unmoderated
IDEC Pharmaceuticals annouced over PRNewswire on May 21 positive results from a Phase III pivotal trial of IDEC-C2B8 as a single-agent treatment for patients with relapsed low-grade or follicular non-Hodgkin's lymphoma cancer. Anybody following this company? I am looking for discussion on this company and its future potential.
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1762Aiming at a Curative Strategy for Follicular Lymphoma: caonline.amcancersoc.orgMaurice Winn15/9/2010
1761You were right all along Mq: rituxan.com 5 year survival zooms up with Rituxan.Maurice Winn-12/9/2007
1760No Mq, it's worse than that. <<i>I guess 5% of people have died whMaurice Winn-7/29/2007
1759Another couple of years and the FDA seems to have finally concluded [duh!] that Maurice Winn-3/26/2006
1758In case the link disappears, here's the executive summary. The full report Maurice Winn112/4/2004
1757Hi Rich. Long time no hear. I hope things are well with you. Things are good Maurice Winn112/4/2004
1756IDEC Pharma upped to Outperform at RBC (IDPH) 33.10 The upgrade from Sector PerfVIXandMore-8/13/2003
1755From Alan Abelson's column in Barrons, re IDPH & BGEN: #reply-19125905Doc Bones-7/19/2003
1754Buyout rumors were posted Fri. on the stocks activity. Scorces message boards, arichardred-5/26/2003
17532 steps forward, 1 step back: From The Street.com's report on DNA's eartuck-4/9/2003
1752Smarter folks than I think rituxan could become a $2+ billion drug. If so, the tuck-2/25/2003
1751Anyone know any recent news explaining the recent weakness? I was looking at bioTom Pulley-2/22/2003
1750<<i>a hot humid world courtesy of the greenhouse gasses. Some of the moMaurice Winn112/31/2002
1749Thanks for your goodwishes. I hope your 2003 approximates what you hope for it,A.J. Mullen-12/31/2002
1748Best wishes Ashley for 2003 and may the world again be a better place than it waMaurice Winn112/31/2002
1747Maurice, I stayed away from your wider argument because I think it has much merA.J. Mullen-12/31/2002
1746Thanks AJ for your always perspicacious consideration and analysis. Being of Maurice Winn112/30/2002
1745First, I understand that your main argument is that a patient has a right to sayA.J. Mullen-12/30/2002
1744Ashley, thanks for pointing that out. I'm with you on resisting those who tMaurice Winn112/29/2002
1743Thanks Robert, I hadn't seen it. I tried reading it but there are weasel Maurice Winn112/29/2002
1742Maurice, I posted this response to the David Miller letter elsewhere, Message 1A.J. Mullen-12/29/2002
1741Maurice, Have you seen this? To:John Metcalf who wrote (7623) From: RobertThe Dodgy Ticker-12/29/2002
1740rant on/ Who's life is it anyway? People claim there is such a thing as freMaurice Winn112/28/2002
1739IDPH was up 1.87 yesterday. However, there was $19.4 million more traded on dowpchristi12534-8/15/2002
1738Strong Rituxan Sales Push Idec Past Estimates [TSCM] By Adam Feuerstein SeniorDoc Bones-7/18/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):